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The activation of ATR-ATRIP in response to double-stranded DNA breaks (DSBs) depends upon ATM in human cells
and Xenopus egg extracts. One important aspect of this dependency involves regulation of TopBP1 by ATM. In Xenopus
egg extracts, ATM associates with TopBP1 and thereupon phosphorylates it on S1131. This phosphorylation enhances the
capacity of TopBP1 to activate the ATR-ATRIP complex. We show that TopBP1 also interacts with the Mre11-Rad50-Nbs1
(MRN) complex in egg extracts in a checkpoint-regulated manner. This interaction involves the Nbs1 subunit of the
complex. ATM can no longer interact with TopBP1 in Nbs1-depleted egg extracts, which suggests that the MRN complex
helps to bridge ATM and TopBP1 together. The association between TopBP1 and Nbs1 involves the first pair of BRCT
repeats in TopBP1. In addition, the two tandem BRCT repeats of Nbs1 are required for this binding. Functional studies
with mutated forms of TopBP1 and Nbs1 suggested that the BRCT-dependent association of these proteins is critical for
a normal checkpoint response to DSBs. These findings suggest that the MRN complex is a crucial mediator in the process
whereby ATM promotes the TopBP1-dependent activation of ATR-ATRIP in response to DSBs.
INTRODUCTION
In eukaryotic cells, various checkpoint mechanisms operate
to prevent the dissemination of genetic errors by cells that
have suffered DNA lesions (Nyberg et al., 2002; Sancar et al.,
2004). Two phosphoinositide kinase-related kinases (PIKKs)
called ATM and ATR function near the apex of key check-
point pathways. ATM is involved in the initial detection of
double-stranded DNA breaks (DSBs) that occur, for exam-
ple, after treatment of cells with ionizing radiation (IR) or
various genotoxic chemicals (Shiloh, 2006). On the other
hand, ATR responds principally to problems that arise at
replication forks (Abraham, 2001; Kumagai and Dunphy,
2006; Cimprich and Cortez, 2008). Interestingly, ATR also
has a role in response to DSBs that involves cooperation
with ATM (Cuadrado et al., 2006; Jazayeri et al., 2006; Myers
and Cortez, 2006; Yoo et al., 2007). Despite their structural
and functional similarities, ATR is essential for cell viability,
whereas ATM is expendable for normal cell proliferation.
One critical function of ATR involves activation of the
downstream checkpoint effector kinase called Chk1 (Guo et
al., 2000; Liu et al., 2000; Zhao and Piwnica-Worms, 2001).
Once activated by ATR, Chk1 phosphorylates and modu-
lates the activity of various proteins, including the cell cycle
regulators Cdc25 and Wee1 (Perry and Kornbluth, 2007).
The collective effect of these phosphorylations is the impo-
sition of a cell cycle arrest until the cell has alleviated the
DNA lesion that initially triggered the ATR-mediated re-
sponse.
In order for ATR to undergo activation and recognize
substrates, it must collaborate with various other proteins.
For example, ATR possesses a stably bound partner protein
called ATRIP (Cortez et al., 2001). Significantly, ATRIP can
interact directly with RPA, a single-stranded DNA-binding
protein (Zou and Elledge, 2003). RPA accumulates in signif-
icant amounts at stalled replication forks, which typically
continue DNA unwinding in the absence of DNA polymer-
ase activity (Walter and Newport, 2000; Byun et al., 2005).
ATR-ATRIP also detects the occurrence of DSBs by associ-
ating with the RPA on single-stranded DNA that arises as a
result of resection at the exposed DNA ends (Cimprich and
Cortez, 2008). Thus, ATR-ATRIP recognizes an array of DNA
lesions that share single-stranded DNA as one structural
feature.
The docking of ATR-ATRIP onto RPA does not affect its
catalytic activity. Instead, an activating protein known as
TopBP1 subsequently associates with ATR-ATRIP and
thereupon stimulates a large increase in its intrinsic kinase
activity toward a range of different substrates (Kumagai et
al., 2006). This process involves the interaction of ATR-
ATRIP with a discrete ATR-activating domain (AAD) within
TopBP1 (Kumagai et al., 2006; Mordes et al., 2008). Another
important step in the checkpoint response to stalled replica-
tion forks entails the interaction between TopBP1 and the
checkpoint clamp comprised of Rad9, Hus1, and Rad1 (the
9-1-1 complex) (Garcia et al., 2005; Delacroix et al., 2007; Lee
et al., 2007). The 9-1-1 complex is deposited onto recessed
DNA ends by a checkpoint clamp-loader complex that con-
tains Rad17 and the four small subunits of replication factor
C (RFC) (Parrilla-Castellar et al., 2004; Sancar et al., 2004). As
is the case with single-stranded DNA, recessed DNA ends
also accumulate at stalled replication forks. The independent
interactions of ATR-ATRIP and TopBP1 with different struc-
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tural features of stalled replication forks may contribute to
the fidelity and efficiency of checkpoint signaling.
ATR-ATRIP also plays a role in checkpoint responses to
DSBs that involves upstream regulation by ATM (Cuadrado
et al., 2006; Jazayeri et al., 2006; Myers and Cortez, 2006). In
particular, ATM appears to control the resection of DNA
ends in a process that depends on the Xmre11-Xrad50-Xnbs1
(MRN) complex. Resection generates single-stranded DNA
that can be recognized sequentially by RPA and ATR-
ATRIP. In addition, our laboratory recently identified ATM
as a TopBP1-interacting protein in Xenopus egg extracts un-
dergoing a checkpoint response to DSBs (Yoo et al., 2007).
We pursued this observation by showing that ATM phos-
phorylates TopBP1 on S1131 and thereby strongly stimulates
the ATR-activating capacity of TopBP1. Significantly, phos-
phorylation of S1131 is required for a proper checkpoint
response to DSBs but apparently not to stalled replication
forks.
In this report, we have identified additional TopBP1-in-
teracting proteins in egg extracts as the three components of
the MRN complex. We have pursued this observation by
showing that the MRN complex is necessary for the recruit-
ment of ATM to TopBP1 in response to DSBs. This step is a




Xenopus egg extracts were prepared as described (Yoo et al., 2004a). Extracts
were treated with 50 g/ml dA70-dT70 (pA-pT) to elicit checkpoint responses
as described (Kumagai and Dunphy, 2000). To prepare egg extracts contain-
ing chromatin with DSBs or stalled DNA replication forks, demembranated
sperm nuclei (1000–3000/l) were incubated in extracts containing 0.05 U/l
EcoRI or 50 g/ml aphidicolin, respectively. For preparation of nuclear
fractions, egg extracts (50 l) containing 3000 sperm nuclei/l were incubated
under the indicated conditions. Nuclear fractions were isolated from the
extracts as described previously (Yoo et al., 2006).
Antibodies
A DNA fragment encoding amino acids 532–762 of Xenopus Nbs1 (Xnbs1) was
generated by PCR and cloned into a pET-His6 expression vector. The His6-
Xnbs1(532–762) protein was expressed in Escherichia coli, isolated with nickel
agarose, and used for production of rabbit antibodies at a commercial facility.
Antiserum against Xmre11 was the generous gift of Dr. V. Costanzo (Clare
Hall Laboratories, United Kingdom). An anti-human Nbs1 antibody was
purchased from Calbiochem (La Jolla, CA). Affinity-purified antibodies
against Xenopus versions of ATM (Xatm) and TopBP1 (XtopBP1) were de-
scribed previously (Yoo et al., 2004b; Kumagai et al., 2006). Anti-human Chk1
phospho-Ser317 and phospho-Ser345 antibodies were obtained from Cell
Signaling Technology (Beverly, MA). Anti-GST, anti-FLAG, anti-human -tu-
bulin, and control rabbit antibodies were purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA), Sigma (St. Louis, MO), Oncogene Research Products
(Boston, MA), and Zymed (South San Francisco, CA), respectively.
Production of Xenopus MRN Components
cDNA clones encoding full-length versions of Xenopus Mre11 (Xmre11) and
Xnbs1 (Costanzo et al., 2001; You et al., 2005) were isolated from a Xenopus
oocyte library by PCR. The sequence encoding Xenopus Rad50 (Xrad50) was
cloned by PCR based on two expressed sequence tags with significant ho-
mology to the 5 and 3 regions of human Rad50, respectively. The full-length
cDNA clone defined a complete open reading frame of 1312 amino acids
(GenBank accession no. FJ436027). The human Nbs1 cDNA clone was gener-
ously supplied by Dr. T. Paull (University of Texas at Austin).
Immunoprecipitation and Immunodepletion
For immunoprecipitations, egg extracts (100 l) were incubated under con-
stant agitation for 45 min at 4°C with Affiprep-protein A beads (Bio-Rad,
Richmond, CA) coated with anti-XtopBP1 (3 g) or anti-Xnbs1 antibodies (3
g). The beads were washed three times with buffer A (10 mM HEPES-KOH, pH
7.5, 150 mM NaCl, 0.5% NP-40, 2.5 mM EGTA, and 20 mM -glycerolphos-
phate), twice with HEPES-buffered saline (HBS; 10 mM HEPES-KOH, pH 7.5,
and 150 mM NaCl), and subjected to SDS-PAGE and immunoblotting. For
immunodepletion of Xnbs1, interphase extracts (100 l) were incubated at 4°C
for 45 min with 20 g of anti-Xnbs1 antibodies bound to 20 l of Affiprep
protein A beads. The same amount of control rabbit IgG was used for mock
depletion. After the incubation, the beads were removed by centrifugation
and the supernatants were treated again for a second round of depletion.
XtopBP1 was immunodepleted as described previously (Yoo et al., 2007).
Production of Recombinant Proteins
PCR-generated DNA fragments encoding Xmre11, Xrad50, and Xnbs1 were
cloned into a pFastBac-FLAG vector to express proteins with a FLAG tag at
the C-terminal end. Untagged versions of Xmre11 and Xnbs1 were prepared
by using a pFastBac that does not encode any tag. Fragments comprising
residues 1-410 and 338-762 of Xnbs1 were prepared by using the pFastBac-GH
vector, which encodes glutathione S-transferase (GST) and His6 tags at the
C-terminal end (Kumagai and Dunphy, 2000). Recombinant baculoviruses
were generated with the Bac-to-Bac system (Invitrogen, Carlsbad, CA). Re-
combinant baculovirus-expressed proteins were produced in Sf9 insect cells
and purified using anti-FLAG agarose beads (Yoo et al., 2007). To produce the
Xenopus MRN complex, Sf9 insect cell were coinfected with three recombinant
baculoviruses (encoding Xmre11, Xrad50-FLAG, and Xnbs1). The complex
was purified from the infected cells with anti-FLAG antibody beads. Recom-
binant, full-length HF-XtopBP1 with both hemagglutinin (HA) and His6 tags
at the N-terminal end and a FLAG tag at the C-terminal end was produced in
baculovirus-infected Sf9 cells by previously described methods (Kumagai and
Dunphy, 2000). The I-II and BRCT I-II versions of XtopBP1 lack residues
96-282 and 360-1485, respectively. These constructs were designed to include
the last 28 amino acids of XtopBP1 (residues 1486-1513), which contain the
nuclear localization sequence (NLS) of the protein. 35S-labeled proteins were
synthesized in vitro with the TnT system (Promega, Madison, WI). The vector
pcDNA3.1 was used for expression of FLAG-tagged human Nbs1 in tissue
culture cells. Point mutants of XtopBP1, Xnbs1, and human Nbs1 were pro-
duced using the QuikChange kit (Stratagene, La Jolla, CA).
Pulldowns of Recombinant XtopBP1 from Xenopus Egg
Extracts
Recombinant HF-XtopBP1 was incubated in egg extracts containing pA-pT
and reisolated as described in a previous publication (Yoo et al., 2007).
XtopBP1-interacting proteins were separated by SDS-PAGE and stained with
Coomassie brilliant blue. Excised bands were cut into 1-mm3 pieces, in-gel
digested with trypsin, and extracted from the gel matrix with acetonitrile and
5% formic acid (Shevchenko et al., 2006). Recovered peptides were subjected
to LC-MS/MS analysis on an LTQ ion trap mass spectrometer (Thermo Fisher
Scientific, San Jose, CA) under the conditions described in Waridel et al.
(2007). The presence of components of the Xenopus MRN complex in the
pulldowns was established by the following criteria. Xmre11 (accession no.
AAD31866) was identified with 38 individual peptides matching to 152
MS/MS spectra and covering 52% of the sequence. Xrad50 (LOC495064
protein, accession no. AAH84223) was identified with 50 individual peptides
matching to 168 MS/MS spectra and covering 53% of the available sequence.
Finally, Xnbs1 (accession no. AAQ82670) was identified with 37 individual
peptides matching to 59 MS/MS spectra and covering 43% of the sequence.
Assay for Binding of Xnbs1 to XtopBP1 in Egg Extracts
Recombinant XtopBP1 (1 g) bound to anti-FLAG antibody beads was incu-
bated for 100 min in egg extracts (50 l) containing 100 g/ml cycloheximide
in the absence or presence of 50 g/ml pA-pT. The beads were isolated by
centrifugation and washed three times with buffer A and twice with HBS.
Bound proteins were subjected to SDS-PAGE and immunoblotting.
Cell Culture and Small Interfering RNA Transfection
HEK293T cells and HeLa cells were maintained in DMEM containing 10%
fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin. A
small interfering RNA (siRNA) duplex specific for Nbs1 with the sense strand
sequence GGAGGAAGAUGUCAAUGUUUU was purchased from Dharma-
con Research (Boulder, CO). siRNA was transfected into HeLa cells with
Lipofectamine 2000 (Invitrogen). Constructs encoding siRNA-resistant ver-
sions of wild-type and 2A (T158A and K160A) human Nbs1 were generated
by changing three nucleotides in the siRNA-targeting region.
Lentivirus Generation and Infection
Sequences encoding siRNA-resistant versions of wild-type and 2A-mutant
human Nbs1 were cloned downstream of the human ubiquitin-C promoter in
the lentivector plasmid FUW. Lentivirus production was performed as de-
scribed (Qin et al., 2003). Briefly, HEK293T cells were transfected by using the
calcium phosphate transfection method. HEK293T cells in 6-cm culture dishes
were transfected with the appropriate lentiviral vector plasmid (5 g) along
with 2.5 g each of the HIV-1 lentiviral packaging constructs pRSV-Rev and
pMDLg/pRRE as well as the vesicular stomatitis virus glycoprotein (VSVG)
expression plasmid pVSV. The viral supernatants were harvested 48 h after
transfection and filtered through a 0.45-m pore size filter. HeLa cells were
infected with virus in presence of 4 g/ml Polybrene (Sigma). Supernatant
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was removed after 8 h and replaced with growth medium. Cells were incu-
bated for 1 d after infection and then transfected with control or Nbs1 siRNA.
After an additional 2 d, cells were exposed to IR (5 Gy) or were mock-treated
in parallel. Whole cell extracts were prepared 2 h later and processed for
SDS-PAGE and immunoblotting.
Kinase Assays
Kinase assays of endogenous Xatm were performed as described previously
with PHAS-I as the substrate (Yoo et al., 2004b).
RESULTS
XtopBP1 Interacts with the MRN Complex in Egg
Extracts
As described previously, we searched for XtopBP1-interact-
ing proteins by performing pulldown experiments with a
recombinant version of XtopBP1 containing the FLAG
epitope (HF-XtopBP1) (Yoo et al., 2007). For this purpose, we
incubated HF-XtopBP1 in Xenopus egg extracts containing
annealed oligomers comprised of dA70 and dT70 (henceforth
referred to as pA-pT). This template elicits the robust acti-
vation of Xchk1 in a process that depends on key upstream
regulators, including XtopBP1, Xatr-Xatrip, and Claspin
(Kumagai and Dunphy, 2000; Kumagai et al., 2004; Hashimoto
et al., 2006; Kumagai et al., 2006). This pathway also requires the
activation of XtopBP1 by Xatm (Yoo et al., 2007). In our earlier
studies, we identified two XtopBP1-interacting proteins as
Xatm and Xatr. In further analyses, we noted that these pull-
downs also contained all three subunits of the MRN complex
(Xmre11, Xrad50, and Xnbs1) (see Materials and Methods).
To assess the specificity of the observed interaction with the
MRN components, we performed reciprocal immunoprecipi-
tation experiments. For these studies, we prepared anti-Xnbs1
antibodies to detect the endogenous MRN complex in egg
extracts. We subjected egg extracts containing pA-pT to immu-
noprecipitation with either anti-XtopBP1 or anti-Xnbs1 anti-
bodies and then probed the immunoprecipitates for Xnbs1 or
XtopBP1, respectively. We could readily detect Xnbs1 in anti-
XtopBP1 immunoprecipitates and vice versa (Figure 1, A and B).
Next, we asked which component(s) of the MRN complex
mediates the interaction with XtopBP1. For this purpose, we
prepared C-terminally FLAG-tagged versions of Xmre11,
Xrad50, and Xnbs1 in baculovirus-infected Sf9 insect cells. Full-
length cDNA clones encoding Xmre11 and Xnbs1 had been
described earlier (Costanzo et al., 2001; You et al., 2005). How-
ever, a Xenopus homologue of Rad50 (Xrad50) had not been
characterized previously. Accordingly, we used DNA primers
based on expressed sequence tags to isolate a full-length cDNA
clone encoding Xrad50 from an oocyte cDNA library. The
predicted sequence of Xrad50 encodes a polypeptide contain-
ing 1312 amino acids with 74.6% overall homology to human
Rad50.
We incubated the FLAG-tagged versions of Xmre11, Xrad50,
and Xnbs1 in egg extracts in the absence or presence of pA-pT.
Next, we retrieved the tagged proteins from the extracts and
probed for XtopBP1. We found that XtopBP1 associated only
with the Xnbs1 subunit (Figure 1C). Furthermore, this binding
was greatly increased in the presence versus absence of pA-pT.
As expected, we could also observe binding of Xatm to both
Xnbs1 and Xmre11 (Lee and Paull, 2007). These interactions
did not depend on the presence of pA-pT. As another means to
confirm the specificity of this interaction, we incubated a 35S-
labeled form of Xnbs1 in egg extracts in the absence or presence
of pA-pT and performed pulldowns with anti-FLAG antibody
beads lacking or containing HF-XtopBP1. We also observed a
specific, checkpoint-regulated interaction between Xnbs1 and
XtopBP1 by this method (Figure 1D).
To pursue these observations further, we prepared the
complete trimeric Xenopus MRN complex and the dimeric
Xmre11-Xrad50 complex (MR) in Sf9 insect cells. It is known
that Mre11 and Rad50 can form a functional complex with a
subset of the activities of the whole MRN complex (Lee and
Paull, 2007). We observed that XtopBP1 could associate with
the Xenopus MRN but not MR complex (Figure 1E). Taken
Figure 1. XtopBP1 interacts in a regulated manner with the Xnbs1
subunit of the MRN complex in Xenopus egg extracts. (A) Control
and anti-XtopBP1 immunoprecipitates (IP) from egg extracts con-
taining pA-pT were immunoblotted for Xnbs1. (B) Control and
anti-Xnbs1 immunoprecipitates from egg extracts containing pA-pT
were immunoblotted for XtopBP1. (C) Anti-FLAG antibody beads
containing no recombinant protein (lanes 1 and 2), Xmre11-FLAG
(lanes 3 and 4), Xnbs1-FLAG (lanes 5 and 6), and Xrad50-FLAG
(lanes 7 and 8) were incubated in egg extracts lacking or containing
pA-pT. Beads were retrieved and immunoblotted with anti-
XtopBP1, anti-Xatm, and anti-FLAG antibodies. (D) Anti-FLAG an-
tibody beads containing no recombinant protein (lanes 3 and 4) or
HF-XtopBP1 (lanes 5 and 6) were incubated in egg extracts contain-
ing 35S-labeled Xnbs1 with or without pA-pT. The beads were
reisolated, and bound 35S-labeled Xnbs1 was detected by SDS-
PAGE and phosphorimaging. Lanes 1 and 2, aliquots of initial
extracts lacking or containing pA-pT. (E) Anti-FLAG antibody
beads containing no recombinant protein (lanes 1 and 2), Xnbs1-
FLAG (lanes 3 and 4), MRN complex (Xmre11, Xrad50-FLAG, and
Xnbs1) (lanes 5 and 6), or MR complex (Xmre11 and Xrad50-FLAG)
(lanes 7 and 8) were incubated in egg extracts lacking or containing
pA-pT. Beads were retrieved and immunoblotted with antibodies
against XtopBP1 and Xatm.
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together, these experiments indicate that XtopBP1 engages
in a checkpoint-regulated interaction with the Xenopus MRN
complex through its Xnbs1 subunit and does not bind de-
tectably to the Xmre11 or Xrad50 proteins.
Xnbs1 Associates with the BRCT I-II Region of XtopBP1
Next, we investigated which region of XtopBP1 is responsi-
ble for association with the MRN complex. XtopBP1 contains
a total of eight BRCT repeats (see Figure 2A). We previously
described various deletion mutants of XtopBP1 that lack one
or more BRCT repeats or the ATR-activating domain (Lee et
al., 2007). Using these mutants, we found that the version of
XtopBP1 lacking the first two BRCT repeats (I-II) was
defective in the interaction with Xnbs1 (Figure 2B). Consis-
tent with this observation, we found that there was also no
binding of Xmre11 or Xatm to the I-II mutant of XtopBP1.
Furthermore, a FLAG-tagged fragment of XtopBP1 contain-
ing only the first two of the eight BRCT repeats could also
bind to Xnbs1 in a checkpoint-regulated manner. Taken
together, these experiments indicate that the BRCT I-II re-
gion of XtopBP1 is both necessary and sufficient for binding
of the MRN complex. Interestingly, this same region of
XtopBP1 is involved in the binding of the Xrad9 subunit of
the Xenopus 9-1-1 complex (Lee et al., 2007).
Various studies have indicated that tandem BRCT repeats
can form a phosphopeptide-binding domain (Caldecott,
2003; Glover et al., 2004). Structure-function analyses have
identified critical residues that form the core of the phos-
phate-binding pocket. Through sequence alignments, we
identified K155 in the first BRCT domain of XtopBP1 as a
likely key residue in such a pocket. However, there is also a
lysine at position 154. Accordingly, we decided to change
both K154 and K155 to alanine and methionine, respectively,
to create the XtopBP1-KKAM mutant. We incubated bacu-
lovirus-expressed, full-length versions of wild-type and
KKAM-mutant HF-XtopBP1 in egg extracts in the absence or
presence of pA-pT and then examined binding of Xnbs1. We
observed that there was virtually no binding of Xnbs1 to the
XtopBP1-KKAM protein (Figure 2C). We obtained similar
results if we examined the binding of Xnbs1 to a KKAM
mutant form of the XtopBP1 fragment containing BRCT
repeats I-II (Figure 2D). Therefore, the putative phosphate-
binding pocket in the BRCT I-II region of XtopBP1 appears
to be critical for regulated binding to the MRN complex.
XtopBP1 Associates with the Tandem BRCT Repeats of
Xnbs1
Having determined what region of XtopBP1 associates with
Xnbs1, we also performed structure-function studies to elu-
cidate what area of Xnbs1 participates in this interaction.
Vertebrate forms of Nbs1 contain a number of identifiable
functional domains (Lee and Paull, 2007; Williams et al.,
2007; Rupnik et al., 2008). The N-terminal region of the
protein contains one forkhead-associated (FHA) domain and
two BRCT domains. The C-terminal area of the protein
possesses two regions that interact with Mre11 and ATM,
respectively. Accordingly, we prepared tagged fragments of
Xnbs1 containing roughly the N-terminal (residues 1-410)
and C-terminal (residues 338-762) halves of the protein. We
incubated these fragments in egg extracts that also con-
tained recombinant HF-XtopBP1. On retrieving the tagged
XtopBP1 protein with anti-FLAG antibody beads, we ob-
served that there was binding of the N-terminal but not
C-terminal fragment of Xnbs1 (Figure 3A).
We proceeded to prepare various deletions of the N-
terminal domain of Xnbs1 in order to define more precisely
the requirements for binding to XtopBP1 (Figure 3, B and E).
We observed that deletion of residues 21–78 of Xnbs1, which
excises most of the FHA domain, significantly reduced but
did not eliminate the binding of XtopBP1. However, any
deletion that compromised either of the BRCT domains (res-
idues 111-197 and 219-327, respectively) dramatically re-
duced interaction with XtopBP1 (Figure 3B). The results of
these binding experiments are summarized in Figure 3E.
Next, we introduced point mutations into the BRCT-con-
taining region of Xnbs1 in order to disable the phosphate-
binding pocket that would be formed by the tandem BRCT
domains. In particular, we changed both T156 and K158 of
Xnbs1 to alanine to create the Xnbs1-2A mutant. Using two
different assay methods, we observed that the Xnbs1-2A
mutant displayed compromised binding to XtopBP1 (Figure
3, C and D). This mutant showed basal binding to XtopBP1
Figure 2. The BRCT I-II region of XtopBP1 is necessary and suffi-
cient for association with Xnbs1. (A) Domains of XtopBP1. Roman
numerals denote the BRCT domains of XtopBP1. Full-length HF-
XtopBP1 (WT) and versions of XtopBP1 lacking residues 96-282
(I-II) or 360-1485 (BRCT I-II) were produced in Sf9 cells. (B) Anti-
FLAG antibody beads containing no recombinant protein (lanes 1
and 2) or the indicated versions of HF-XtopBP1 (lanes 3–8) were
incubated in egg extracts in the absence or presence of pA-pT. Beads
were retrieved and immunoblotted with anti-Xnbs1, anti-Xmre11,
anti-Xatm, and anti-FLAG antibodies. (C) Wild-type and KKAM
versions of HF-XtopBP1 on anti-FLAG antibody beads were incu-
bated in egg extracts lacking or containing pA-pT. Beads were
reisolated and immunoblotted with anti-Xnbs1 (top) and anti-FLAG
antibodies (bottom). (D) Anti-FLAG antibody beads containing no
recombinant protein (lanes 1 and 2) or either the wild-type or
KKAM versions of the XtopBP1 BRCT I-II construct (lanes 3–6) were
incubated in egg extracts in the absence or presence of pA-pT. Beads
were retrieved and immunoblotted with the antibodies against
Xnbs1 (top). The wild-type and KKAM versions of the BRCT I-II
fragment on immunoblots were stained with Coomassie brilliant
blue (CBB) (bottom).
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in the absence of the checkpoint-inducing DNA template
pA-pT. However, there was little or no increase in the bind-
ing of Xnbs1-2A to XtopBP1 in the presence of pA-pT, in
contrast to the strong increase in the binding of wild-type
Xnbs1 that occurred under the same conditions. Finally, we
mutated a potential ATM/ATR phosphorylation site at S275
in the second BRCT domain of Xnbs1 to a nonphosphorylat-
able form. This site is conserved in human Nbs1 (Lee and Paull,
2007). However, the resulting Xnbs1-S275A mutant displayed
normal binding to XtopBP1. Taken together, these results in-
dicate that Xnbs1 must contain intact tandem BRCT domains in
order to undergo checkpoint-stimulated binding to XtopBP1.
The Xnbs1-associating Region of XtopBP1 Is Critical for
a Checkpoint Response to DSBs in Egg Extracts
We next investigated whether the interaction between XtopBP1
and Xnbs1 is important for the activation of Xatr-Xatrip in
response to DSBs in egg extracts. In one set of experiments, we
focused on the KKAM mutant of XtopBP1 that cannot interact
with Xnbs1 in a regulated manner. For these experiments, we
immunodepleted the endogenous XtopBP1 from egg extracts
and replaced it with either wild-type or KKAM versions of
HF-XtopBP1 (Figure 4A). Subsequently, we examined check-
point responses to DNA templates containing exposed double-
stranded DNA ends. More specifically, we added pA-pT to egg
extracts or treated egg extracts containing reconstituted sperm
nuclei with EcoRI (to create DSBs in the chromatin) (Kobayashi
et al., 2002; Yoo et al., 2004b). We observed that the phosphor-
ylation of Xchk1 in response to either pA-pT or EcoRI was
greatly compromised in egg extracts containing the XtopBP1-
KKAM mutant (Figure 4, B and C). Thus, a normal checkpoint
response to DSBs in egg extracts depends upon the ability of
XtopBP1 to interact with the MRN complex in a DNA damage–
dependent manner.
Role of Xnbs1 in the Regulation of XtopBP1 by Xatm in
Egg Extracts
We then turned to the functional role of Xnbs1 in the Xatm-
dependent activation of Xatr-Xatrip in egg extracts. For these
experiments, we removed the endogenous Xnbs1 from egg
Figure 3. The tandem BRCT domains of Xnbs1
are required for interaction with XtopBP1. (A)
Recombinant HF-XtopBP1 on anti-FLAG anti-
body beads was incubated in egg extracts con-
taining N-terminal (lanes 3 and 4) or C-terminal
fragments of Xnbs1 (lanes 7 and 8) in the ab-
sence or presence of pA-pT. Beads were reiso-
lated and immunoblotted for GST. Lanes 1, 2, 5,
and 6, initial extract aliquots. (B) 35S-Labeled
versions of full-length Xnbs1 (WT) (lanes 1–4)
and the 315–361, 21–255, and 21–291 dele-
tion mutants of Xnbs1 (lanes 5–16) were incu-
bated in egg extracts containing HF-XtopBP1
bound to anti-FLAG antibody beads in the ab-
sence or presence of pA-pT. The beads were
isolated, and bound 35S-labeled proteins were
detected by SDS-PAGE and phosphorimaging
(lanes 3, 4, 7, 8, 11, 12, 15, and 16). Lanes 1, 2, 5,
6, 9, 10, 13, and 14, initial extract aliquots. (C)
35S-Labeled versions of wild-type, S257A, and
2A Xnbs1 were analyzed for binding to
XtopBP1 as described in B. (D) Wild-type and
2A mutant versions of Xnbs1-FLAG on anti-
FLAG antibody beads were incubated in egg ex-
tracts lacking or containing pA-pT. Beads were
reisolated and immunoblotted for XtopBP1. (E)
Summary of the abilities of the indicated forms of
Xnbs1 to interact with XtopBP1.
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extracts with anti-Xnbs1 antibodies. As shown in Figure 5A,
we were able to achieve an essentially complete depletion of
Xnbs1 from the extracts. Previous studies have indicated
that the MRN complex is necessary for the activation of
Xatm in response to DNA templates with exposed double-
stranded DNA ends (Costanzo et al., 2004; You et al., 2005;
You et al., 2007). Consistent with these findings, we found
that there was no activation of Xatm in Xnbs1-depleted
extracts containing the double-stranded oligonucleotide
template pA-pT (Figure 5C). We also examined whether
Xnbs1 is necessary for the activation of Xchk1 in response to
DSBs. This issue had not been examined explicitly before.
We observed that there was no phosphorylation of Xchk1 in
Xnbs1-depleted extracts in response to pA-pT (Figure 5D).
Next, we asked whether binding of Xatm to XtopBP1 in
egg extracts was dependent on Xnbs1. For this purpose, we
immunoprecipitated XtopBP1 from mock-depleted and
Xnbs1-depleted extracts that had been incubated in the ab-
sence or presence of pA-pT. We observed that there was no
binding of Xatm to XtopBP1 in Xnbs1-depleted extracts (Fig-
ure 5E). Furthermore, we were able to rescue this binding by
addition of a recombinant version of the Xenopus MRN
complex composed of FLAG-tagged Xrad50 and untagged
forms of Xmre11 and Xnbs1 (Figure 5, A, B, and E). This
finding suggests that the MRN complex directly or indi-
rectly bridges together Xatm and XtopBP1 in response to the
occurrence of DSBs. Unfortunately, however, we were not
able to rescue the activation of Xatm or Xchk1 in Xnbs1-
depleted extracts containing pA-pT with the recombinant
Xenopus MRN complex. Thus, this recombinant complex
appears to be partly but not fully functional. Therefore, we
were not able to test whether an MRN complex containing
the Xnbs1-2A mutant is defective in checkpoint signaling.
Human Cells Harboring the Nbs1-2A Mutant Are
Defective in the IR-induced Activation of Chk1
As an alternative means to assess the functional importance
of the TopBP1-interacting region on Nbs1 for checkpoint
signaling, we turned to an siRNA-based strategy in human
cells. For this purpose, we treated HeLa cells with siRNA
directed against Nbs1. Before this treatment, we infected the
cells with recombinant lentiviruses encoding various forms
of human Nbs1 that were resistant to the siRNA. For these
experiments, we prepared a mutant form of human Nbs1 in
which T158 and K160 were changed to alanine. This mutant,
which we called Nbs1-2A, is equivalent to the Xnbs1-2A
mutant from the Xenopus system (Figure 6A).
As shown in Figure 6B, we used an siRNA that caused a
pronounced depletion of Nbs1. Under the same conditions,
a control siRNA had no effect on Nbs1. In these control cells,
there was a significant increase in the phosphorylation of
Chk1 on S317 in response to IR. This increase was abolished
in cells treated the Nbs1 siRNA. Furthermore, the IR-in-
duced phosphorylation of Chk1 on S317 was restored by
expression of wild-type, siRNA-resistant Nbs1. However,
there was no rescue of this phosphorylation in cells infected
with a lentivirus that expressed the Nbs1-2A mutant. We
verified that this human mutant protein was also defective
for binding to TopBP1 (Figure 6C). Taken together, these
experiments indicate that Nbs1 must possess an intact
BRCT-containing region in order for cells to mount a normal
checkpoint response to DSBs.
DISCUSSION
In this report, we have probed further into the regulation of
XtopBP1 in response to DSBs. Toward this end, we have
analyzed the functional significance of the interaction of
XtopBP1 with additional proteins that we have identified in
pulldown experiments with Xenopus egg extracts. Previ-
ously, we described a specific association between XtopBP1
and Xatm in egg extracts containing a DNA template that
mimics DSBs (Yoo et al., 2007). We pursued this observation
Figure 4. The KKAM mutant of XtopBP1 is defective in the check-
point response to DSBs. (A) Egg extracts were mock-depleted with
control antibodies (lane 1) or immunodepleted with anti-XtopBP1
antibodies (lanes 2–4). Extracts were supplemented with no recom-
binant protein (lane 2), wild-type HF-XtopBP1 (lane 3), or KKAM
HF-XtopBP1 (lane 4). (B) The extracts from A were incubated with
35S-Xchk1 in the absence or presence of pA-pT as indicated. Extracts
were subjected to SDS-PAGE and phosphorimaging. (C) Egg ex-
tracts were mock-depleted with control antibodies (lanes 1 and 2) or
immunodepleted with anti-XtopBP1 antibodies (lanes 3–5). Extracts
were later supplemented with sperm chromatin and no recombi-
nant protein (lanes 1–3), wild-type HF-XtopBP1 (lane 4), or KKAM
HF-XtopBP1 (lane 5). Extracts were incubated with 35S-Xchk1 in the
absence (lane 1) or presence of EcoRI (lanes 2–5). Nuclear fractions
from the extracts were subjected to SDS-PAGE and processed for
phosphorimaging (top) or immunoblotting with the indicated anti-
bodies (middle and bottom).
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by showing that Xatm phosphorylates XtopBP1 on S1131
and thereby enhances its capacity to activate the Xatr-Xatrip
complex. However, it was not clear whether Xatm bound
directly to XtopBP1 or through an intermediary protein(s).
In the present study, we have identified additional XtopBP1-
associating proteins as the three subunits of the Xenopus
MRN complex (Xmre11, Xrad50, and Xnbs1). Furthermore,
we have established that this binding appears to occur
largely if not exclusively through the Xnbs1 component of
the complex. Recent studies have indicated that TopBP1 also
associates with Nbs1 in human cells (Morishima et al., 2007).
Our results indicate that this interaction is critical for the
recruitment of Xatm to XtopBP1. In particular, there is no
binding of Xatm to XtopBP1 in egg extracts that have been
depleted of the Xnbs1 protein. Therefore, the MRN complex
appears to be acting as a mediator between Xatm and
XtopBP1 (see Figure 7).
It is well established that the MRN complex plays crucial
roles in the initial stages of cellular responses to DSBs (Lee
and Paull, 2007; Williams et al., 2007; Rupnik et al., 2008).
This complex can associate with broken DNA ends directly.
Moreover, it accumulates in more substantial amounts at
regions of damage in a manner that depends on phosphor-
ylated H2AX. On arrival at DNA lesions, the MRN complex
carries out multiple functions that include processing DNA
structures and regulation of checkpoint signaling. For exam-
ple, the MRN complex promotes the resection of broken
DNA ends. This nucleolytic processing helps to amplify
checkpoint signaling by creating significant amounts of sin-
gle-stranded DNA in the proximity of DNA breaks. The
MRN complex also appears to play a critical role in the
process whereby ATM becomes converted from inactive
dimers to active monomers. In the human and Xenopus
systems, the activated form of ATM undergoes autophos-
phorylation on S1981, which serves as a useful marker for
the presence of DSBs (Bakkenist and Kastan, 2003; You et al.,
2005).
The MRN complex also promotes the activation of ATR-
ATRIP in response to DSBs (Cuadrado et al., 2006; Jazayeri et
al., 2006; Myers and Cortez, 2006). These initial studies es-
tablished that this regulatory connection involved the ability
of the MRN complex to mediate the resection of DNA at
DSBs. The resulting stretches of single-stranded DNA would
be able to recruit successively RPA and ATR-ATRIP. Ac-
cording to this scenario, ATM would promote the activation
of ATR-ATRIP by facilitating the creation of a structure (i.e.,
RPA-coated, single-stranded DNA) that is important for the
activation of ATR-ATRIP under usual circumstances. The
MRN complex serves as an integral component in this train
of events through its roles in both the activation of ATM and
the resection of DNA.
However, our recent studies with Xenopus egg extracts
have revealed additional aspects of this regulatory
scheme. Consistent with the studies in human cells, the
activation of Xatr-Xatrip in egg extracts containing DSBs
is likewise dependent on Xatm. However, we recently
discovered that XtopBP1 also plays a pivotal role this
process (Yoo et al., 2007). In particular, Xatm associates
with XtopBP1 and strongly stimulates its ATR-activating
capacity; this step involves the Xatm-catalyzed phosphor-
ylation of XtopBP1 on a well-conserved serine residue at
position 1131. In the present study, we have shown that
the Xenopus version of the MRN complex plays a role in
the Xatm-dependent activation of Xatr-Xatrip in egg ex-
tracts apart from its presumed functions in resection of
DNA and activation of Xatm. We have found that Xatm
can no longer associate with XtopBP1 in DSB-containing
egg extracts that lack a functional MRN complex (owing
to depletion of the Xnbs1 subunit). Thus, the MRN com-
plex appears to act as a mediator between Xatm and
XtopBP1 in this context.
We have demonstrated that Xnbs1 interacts with a critical
region of XtopBP1. More specifically, it associates with the
N-terminal region of the protein that contains its first two
BRCT repeats. The docking of Xnbs1 onto the BRCT I-II
region of XtopBP1 appears to be functionally significant. In
particular, a version of XtopBP1 containing point mutations
in critical residues in the BRCT I-II region (the KKAM mu-
tant) is defective in mediating a checkpoint response to DSBs
in egg extracts. Intriguingly, this same region of TopBP1
Figure 5. The MRN complex mediates associ-
ation of Xatm with XtopBP1 in egg extracts
containing DSBs. (A) Immunodepletion of
Xnbs1. Egg extracts were mock-depleted with
control antibodies (lane 1) or immunodepleted
with anti-Xnbs1 antibodies (lanes 2 and 3). Sub-
sequently, no recombinant protein (lane 2) or
Xenopus MRN complex (Xmre11, Xrad50-
FLAG, and Xnbs1) was added back to the
depleted extracts (lane 3). Extracts were im-
munoblotted for Xnbs1. (B) A preparation of
recombinant MRN complex (Xmre11, Xrad50-
FLAG, and Xnbs1) (lane 2) that had been iso-
lated from in Sf9 insect cells was stained with
Coomassie brilliant blue. Lane 1 contains
marker proteins (molecular mass indicated in
kilodaltons). (C) Xatm was immunoprecipi-
tated from mock-depleted (lanes 1 and 2) or
Xnbs1-depleted extracts (lane 3) lacking or con-
taining pA-pT. The anti-Xatm immunoprecipi-
tates were incubated in the presence of
[-32P]ATP with the substrate protein PHAS-I.
Samples were processed for phosphorimaging
(top) and staining with Coomassie brilliant blue
(bottom). (D) Egg extracts were mock-depleted with control antibodies (lanes 1 and 2) or immunodepleted with anti-Xnbs1 antibodies (lane
3). The depleted extracts were incubated with 35S-Xchk1 in the absence or presence of pA-pT. Extracts were subjected to SDS-PAGE and
phosphorimaging. (E) The indicated extracts from A were incubated in the absence (lane 1) or presence of pA-pT (lanes 2–4). XtopBP1 was
immunoprecipitated from the extracts. Immunoprecipitates were subjected to SDS-PAGE and immunoblotted for Xatm.
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interacts with the 9-1-1 complex at stalled replication forks
in vertebrates (Delacroix et al., 2007; Lee et al., 2007). There-
fore, it appears that the BRCT I-II region of XtopBP1 may
be a conduit for the activation of Xatr-Xatrip in response
to a variety of distinct DNA lesions. The fact that this
region interacts with a number of different components
(e.g., MRN, the 9-1-1 complex, and possibly other factors)
does complicate somewhat the interpretation of our re-
sults. However, the MRN complex is a well-established
regulatory binding partner of ATM. Therefore, we believe
that it is reasonable to propose that the failure of the
XtopBP1-KKAM mutant to interact with the MRN com-
plex (and thus Xatm) would plausibly explain why this
mutant cannot mediate the Xatm-dependent activation of
Xatr in response to DSBs.
Furthermore, we have established that Xnbs1 must con-
tain intact tandem BRCT domains in order to interact with
XtopBP1 in a regulated manner. To evaluate the func-
tional significance of this interaction with regard to the
TopBP1-interacting site on Nbs1, we adopted an si-RNA–
based approach in human cells. By this means, we were
able to establish that Nbs1 must contain intact BRCT
domains in order for human cells to carry out the activa-
tion of Chk1 in response to IR-induced DSBs.
In principle, the XtopBP1 and Xnbs1 proteins in egg
extracts could associate directly by means of their BRCT-
containing regions. However, the findings that this inter-
action is highly regulated and depends on intact phos-
phopeptide-binding pockets in the relevant BRCT
domains of both proteins tend to argue against this
model. Nonetheless, we cannot rule out the possibility
that these mutations in XtopBP1 and Xnbs1 would com-
promise phosphorylation-independent interactions.
Another possibility is that an additional protein(s) bridges
together XtopBP1 and the MRN complex in egg extracts.
One potential candidate would be the putative Xenopus ho-
mologue of Mdc1 (Xmdc1). In human cells, localization of
the MRN complex to IR-induced foci depends on Mdc1
(Goldberg et al., 2003; Stewart et al., 2003). Furthermore,
Mdc1 interacts with Nbs1 in a highly specific manner (Chap-
man and Jackson, 2008; Melander et al., 2008; Spycher et al.,
2008; Wu et al., 2008). Interestingly, Mdc1 and the MRN
complex interact in a constitutive manner in human cells,
but the binding of XtopBP1 and the MRN complex is highly
regulated in egg extracts. Further studies will be required to
elucidate the exact mechanism of the association between
XtopBP1 and Xnbs1.
In closing, we have obtained further insight into how cells
activate ATR-ATRIP in response to DSBs. In the future, it
will be interesting to compare and contrast how responses to
different checkpoint-inducing structures manifest them-
selves through distinct interactions of TopBP1 with other
checkpoint proteins.
Figure 6. Human cells harboring the Nbs1-2A mutant are de-
fective in the checkpoint response to IR. (A) Sequence alignment
of Xenopus and human Nbs1 around critical residues in the first
BRCT domain. (B) HeLa cells were infected with lentiviruses
expressing GFP (lanes 1– 4) or either wild-type or 2A versions of
human Nbs1 (lanes 5 and 6). Control or Nbs1 siRNA was trans-
fected into these infected cells as indicated. Cells were mock-
treated or exposed to IR. Cell extracts were prepared 2 h later and
processed for immunoblotting with the indicated antibodies. (C)
HeLa cells were transfected control vector (lanes 1 and 2) or a
vector expressing either wild-type (lanes 3 and 4) or 2A versions
(lanes 5 and 6) of FLAG-tagged human Nbs1. At 48 h after
transfection, cells were treated as described in B. Anti-FLAG
immunoprecipitates from cell lysates were immunoblotted with
anti-TopBP1 and anti-FLAG antibodies.
Figure 7. Model for functional interactions between ATM, the
MRN complex, and TopBP1 in response to DSBs. See text for details.
The indicated associations are not necessarily direct.
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